Shared on07 Aug 25Fair value Decreased 8.48%
The consensus analyst price target for QuidelOrtho has been revised downward, primarily reflecting a sharp deterioration in profitability—evidenced by a collapse in net profit margin and a spike in the future P/E ratio—with fair value lowered from $47.14 to $43.57. What's in the News QuidelOrtho reiterated its full year 2025 earnings guidance, with expected revenues between $2.60 billion and $2.81 billion.
Shared on24 Apr 25Fair value Decreased 3.65%
AnalystConsensusTarget has decreased profit margin from 12.9% to 2.6% and increased future PE multiple from 12.1x to 59.0x.
Shared on17 Apr 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on09 Apr 25Fair value Decreased 0.28%
AnalystConsensusTarget has increased revenue growth from 1.9% to 2.1%.
Shared on02 Apr 25Fair value Decreased 0.91%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on26 Mar 25Fair value Increased 7.08%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.